Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Summary
The goal of this observational study is to learn about the long-term effects of neoadjuvant immunotherapy in patients with lung cancer. The main questions it aims to answer are: * Does pneumonectomy bring more benefits for pateints than lobectomy? * Does surgery bring more benefits for patients than non-surgery modalities (such as radiotherapy) after neoadjuvnat immunotherapy? Participants will receive neoadjuvant treatment and the study will analyze the data.
Official title: Effects of Neoadjuvant Immunotherapy on Patients With Lung Cancer: a Prospective, Observational Study
Key Details
Gender
All
Age Range
18 Years - 79 Years
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2025-04-20
Completion Date
2030-04-14
Last Updated
2025-09-10
Healthy Volunteers
Not specified
Conditions
Interventions
Pneumonectomy
Patients will receive pneumonectomy after neoadjuvant treatment
lobectomy
Patients will receive lobectomy after neoadjuvant immunotherapy.
radiotherapy
Patients will receive radiotherapy after neoadjuvant immunotherapy.
Anti-Tumor Drugs
Patients will receive anti-tumor drugs.
Locations (1)
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, China